Filing Details
- Accession Number:
- 0001415889-25-002623
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-31 21:35:10
- Reporting Period:
- 2025-01-29
- Accepted Time:
- 2025-01-31 21:35:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2010019 | Solomon Moshkevich | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | President, Clinicaldiagnostics | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-29 | 1,178 | $165.87 | 139,056 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-29 | 4,020 | $165.87 | 135,486 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-29 | 3 | $167.36 | 135,483 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023.
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024.
Billionaire Hedge Funds
